IDWeek 2021: Clinical Impact of New Data on Vaccine-Preventable Diseases

Apply new and emerging management options for vaccine-preventable diseases presented at IDWeek 2021 featuring expert faculty analysis in a webinar podcast downloadable slideset and commentary.

Share

Program Content

Activities

  • Slides: Vaccine-Preventable Diseases
    Key Studies of Vaccine-Preventable Diseases Influencing My Practice Following IDWeek 2021
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 03, 2021

    Expires: November 02, 2022

  • Video Recap: Vaccine-Preventable Diseases
    Key Studies of Vaccine-Preventable Diseases Influencing My Practice Following IDWeek 2021—Rapid Recap by Martin Mahoney, MD, PhD
    Conference Coverage
    Multimedia
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 11, 2021

    Expires: November 10, 2022

  • ClinicalThought: Pneumococcal Immunization
    Updates on Pneumococcal Vaccines: My Take on the Latest IDWEEK 2021 Data
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: November 19, 2021

    Expires: November 18, 2022

  • Podcast: Vaccine-Preventable Diseases
    Key Studies on Vaccine-Preventable Diseases Influencing My Practice Following IDWeek 2021—Audio Recap
    Conference Coverage
    Podcast Episodes
    Congratulations: You achieved a completion on 04/09/2022

    Released: December 06, 2021

    Expires: December 05, 2022

Faculty

cover img faculity

Paul G. Auwaerter, MD

Sherrilyn and Ken Fisher Professor of Medicine
Clinical Director
Division of Infectious Diseases
Johns Hopkins University School of Medicine
Baltimore, Maryland

cover img faculity

Martin C. Mahoney, MD, PhD

Professor of Oncology
Department of Internal Medicine
Roswell Park Comprehensive Cancer Center
Buffalo, New York

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Janssen Therapeutics Division of Janssen Products

Merck Sharp & Dohme Corp.